{"DataElement":{"publicId":"8035844","version":"1","preferredName":"Change ALK Tyrosine Kinase Receptor Nucleotide Sequence And/Or Amino Acid Sequence Detection Text","preferredDefinition":"A description of nucleotide and/or amino acid sequencing change(s) detected in the ALK tyrosine kinase receptor.","longName":"ALK_SEQ_CHNG_DECT_TXT","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"8035843","version":"1","preferredName":"Change ALK Tyrosine Kinase Receptor Nucleotide Sequence And/Or Amino Acid Sequence Detection","preferredDefinition":"The act of alteration or modification; changed or altered in form or character.:ALK tyrosine kinase receptor (1620 aa, ~176 kDa) is encoded by the human ALK gene. This protein is involved in ligand binding, tyrosine phosphorylation and signal transduction._The sequence of nucleotide residues along an RNA or DNA chain._Used to indicate that either or both of two items or options may be valid._The sequence of amino acids along a polypeptide chain._The activity of perceiving, discerning, discovering or identifying.","longName":"3028516v1.0:8035878v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2732929","version":"1","preferredName":"Change","preferredDefinition":"The act of alteration or modification; changed or altered in form or character.","longName":"C25446","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Change","conceptCode":"C25446","definition":"The act of alteration or modification; changed or altered in form or character.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"478BE41F-83EF-59E6-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-03-03","endDate":null,"createdBy":"UMLLOADER_STUDYCAL","dateCreated":"2008-03-03","modifiedBy":"ONEDATA","dateModified":"2008-03-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"11334664","version":"1","preferredName":"ALK Tyrosine Kinase Receptor Nucleotide Sequence And/Or Amino Acid Sequence Detection","preferredDefinition":"ALK tyrosine kinase receptor (1620 aa, ~176 kDa) is encoded by the human ALK gene. This protein is involved in ligand binding, tyrosine phosphorylation and signal transduction._The sequence of nucleotide residues along an RNA or DNA chain._Used to indicate that either or both of two items or options may be valid._The sequence of amino acids along a polypeptide chain._The activity of perceiving, discerning, discovering or identifying.","longName":"11334664v1.00","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ALK Tyrosine Kinase Receptor","conceptCode":"C27032","definition":"ALK tyrosine kinase receptor (1620 aa, ~176 kDa) is encoded by the human ALK gene. This protein is involved in ligand binding, tyrosine phosphorylation and signal transduction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Nucleotide Sequence","conceptCode":"C45374","definition":"The sequence of nucleotide residues along an RNA or DNA chain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Amino Acid Sequence","conceptCode":"C13187","definition":"The sequence of amino acids along a polypeptide chain.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Detection","conceptCode":"C16210","definition":"The act of perceiving, discerning, discovering, or identifying.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9D2DCF4-C189-2110-E053-731AD00A0687","latestVersionIndicator":"Yes","beginDate":"2022-09-29","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2022-09-29","modifiedBy":"KUMMEROA","dateModified":"2022-09-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7A0FF99-03FA-4BCD-E053-4EBD850A81FC","latestVersionIndicator":"Yes","beginDate":"2022-02-09","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2022-02-09","modifiedBy":"KUMMEROA","dateModified":"2022-09-29","changeDescription":"2/9/2022 created for ANBL study, wz.","administrativeNotes":"2022.9.29 Reviewed, cleaned up and released. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6784451","version":"1","preferredName":"255 Character Text","preferredDefinition":"The words of something written.","longName":"6784451v1.0","context":"OCCPR","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"255","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234203","version":"1","preferredName":"Text","preferredDefinition":"Text; the words of something written.","longName":"C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F89B-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8BA00B33-81DA-0AB8-E053-F662850A521F","latestVersionIndicator":"Yes","beginDate":"2019-06-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-06-18","modifiedBy":"KNABLEJ","dateModified":"2020-06-23","changeDescription":"11/10/19 jk Released per CPTAC SME (Linda) for Medical History CRF.  6-18-19 tt created for CPTAC Medical History CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"If tumor is positive for variant of unknown significance, Nucleotide and/or amino acid change(s) detected (e.g. C.3875C>G or p.I1290K):","url":null,"context":"COG"},{"name":"COG CRF Text 2","type":"Alternate Question Text","description":"If tumor is positive for likely benign variant, Nucleotide and/or amino acid change(s) detected (e.g. C.3875C>G or p.I1290K):","url":null,"context":"COG"},{"name":"PQT","type":"Preferred Question Text","description":"Specify nucleotide and/or amino acid sequencing change(s) detected in the ALK tyrosine kinase receptor:","url":null,"context":"COG"},{"name":"COG CRF Text 3","type":"Alternate Question Text","description":"Nucleotide and/or amino acid change(s) detected:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D79BF87A-5780-42B4-E053-4EBD850A0DDD","latestVersionIndicator":"Yes","beginDate":"2022-02-09","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2022-02-09","modifiedBy":"KUMMEROA","dateModified":"2022-11-02","changeDescription":"2/9/2022 created for ANBL study, wz.","administrativeNotes":"2022.9.29 Reviewed. cleaned up and released. ak","unresolvedIssues":null,"deletedIndicator":"No"}}